{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:49:18Z","timestamp":1794322158595,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39259"],"award-info":[{"award-number":["RFA-2203-39259"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of the Assistant Secretary of Defense for Health Affairs through the (Multiple Sclerosis Research Program) under Award No."},{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["525895"],"award-info":[{"award-number":["525895"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["525895"],"award-info":[{"award-number":["525895"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["525895"],"award-info":[{"award-number":["525895"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007202","name":"Gouvernement du Canada | Instituts de Recherche en Sant\u00e9 du Canada | CIHR Skin Research Training Centre","doi-asserted-by":"publisher","award":["525895"],"award-info":[{"award-number":["525895"]}],"id":[{"id":"10.13039\/501100007202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1423841"],"award-info":[{"award-number":["1423841"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1423841"],"award-info":[{"award-number":["1423841"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1423841"],"award-info":[{"award-number":["1423841"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novartis"},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41590-025-02359-5","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:02:15Z","timestamp":1767369735000},"page":"48-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury"],"prefix":"10.1038","volume":"27","author":[{"given":"Ikbel","family":"Naouar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Pangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-453X","authenticated-orcid":false,"given":"Michelle","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-2100","authenticated-orcid":false,"given":"Syed Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-1449","authenticated-orcid":false,"given":"Kevin","family":"Champagne-Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0838-7206","authenticated-orcid":false,"given":"Jyot","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6991-7368","authenticated-orcid":false,"given":"Angela","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5305-8956","authenticated-orcid":false,"given":"Jennifer S. Y.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizah N.","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-2404","authenticated-orcid":false,"given":"Elisabeth","family":"P\u00f6ssnecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Spring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Sled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-2032","authenticated-orcid":false,"given":"Bruno","family":"Cenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nuesslein-Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-5233","authenticated-orcid":false,"given":"Jeffrey L.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-1872","authenticated-orcid":false,"given":"Anne-Katrin","family":"Pr\u00f6bstel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-4334","authenticated-orcid":false,"given":"Daniel S.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4576-6168","authenticated-orcid":false,"given":"Jennifer L.","family":"Gommerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-5988","authenticated-orcid":false,"given":"Valeria","family":"Ramaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"2359_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205\u2013217 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"2359_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","volume":"43","author":"NB Pikor","year":"2015","unstructured":"Pikor, N. B. et al. Integration of Th17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity 43, 1160\u20131173 (2015).","journal-title":"Immunity"},{"key":"2359_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E. & Aloisi, F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14, 164\u2013174 (2004).","journal-title":"Brain Pathol."},{"key":"2359_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ana.25365","volume":"84","author":"RJ Bevan","year":"2018","unstructured":"Bevan, R. J. et al. Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Ann. Neurol. 84, 829\u2013842 (2018).","journal-title":"Ann. Neurol."},{"key":"2359_CR5","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell, O. W. et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134, 2755\u20132771 (2011).","journal-title":"Brain"},{"key":"2359_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.22230","volume":"68","author":"R Magliozzi","year":"2010","unstructured":"Magliozzi, R. et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 68, 477\u2013493 (2010).","journal-title":"Ann. Neurol."},{"key":"2359_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","volume":"72","author":"R Magliozzi","year":"2013","unstructured":"Magliozzi, R. et al. B-cell enrichment and Epstein\u2013Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J. Neuropathol. Exp. Neurol. 72, 29\u201341 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2359_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi, R. et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089\u20131104 (2007).","journal-title":"Brain"},{"key":"2359_CR9","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188\u20132197 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2359_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8652463","volume":"2017","author":"G Makshakov","year":"2017","unstructured":"Makshakov, G. et al. Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis. Neurol. Res. Int. 2017, 8652463 (2017).","journal-title":"Neurol. Res. Int."},{"key":"2359_CR11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jon.12774","volume":"30","author":"DS Titelbaum","year":"2020","unstructured":"Titelbaum, D. S. et al. Leptomeningeal enhancement on 3D-FLAIR MRI in multiple sclerosis: systematic observations in clinical practice. J. Neuroimaging 30, 917\u2013929 (2020).","journal-title":"J. Neuroimaging"},{"key":"2359_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","volume":"85","author":"M Absinta","year":"2015","unstructured":"Absinta, M. et al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 85, 18\u201328 (2015).","journal-title":"Neurology"},{"key":"2359_CR13","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","volume":"378","author":"L Kappos","year":"2011","unstructured":"Kappos, L. et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 378, 1779\u20131787 (2011).","journal-title":"Lancet"},{"key":"2359_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032713-120227","volume":"32","author":"L Steinman","year":"2014","unstructured":"Steinman, L. Immunology of relapse and remission in multiple sclerosis. Annu. Rev. Immunol. 32, 257\u2013281 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"2359_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0404.2006.00615.x","volume":"183","author":"L Bo","year":"2006","unstructured":"Bo, L., Geurts, J. J., Mork, S. J. & van der Valk, P. Grey matter pathology in multiple sclerosis. Acta Neurol. Scand. Suppl. 183, 48\u201350 (2006).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"2359_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","volume":"35","author":"A Peters","year":"2011","unstructured":"Peters, A. et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35, 986\u2013996 (2011).","journal-title":"Immunity"},{"key":"2359_CR17","doi-asserted-by":"crossref","unstructured":"Zuo, M. et al. Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation. JCI Insight 7 (2022).","DOI":"10.1172\/jci.insight.158144"},{"key":"2359_CR18","doi-asserted-by":"crossref","unstructured":"Ward, L. A. et al. Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight 5 (2020).","DOI":"10.1172\/jci.insight.132522"},{"key":"2359_CR19","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1021\/acs.jmedchem.9b01916","volume":"63","author":"D Angst","year":"2020","unstructured":"Angst, D. et al. Discovery of LOU064 (remibrutinib), a potent and highly selective covalent inhibitor of Bruton\u2019s tyrosine kinase. J. Med. Chem. 63, 5102\u20135118 (2020).","journal-title":"J. Med. Chem."},{"key":"2359_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02877-9","volume":"20","author":"B Nuesslein-Hildesheim","year":"2023","unstructured":"Nuesslein-Hildesheim, B. et al. Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis. J. Neuroinflammation 20, 194 (2023).","journal-title":"J. Neuroinflammation"},{"key":"2359_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2359_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/brain\/awab045","volume":"144","author":"P Bhargava","year":"2021","unstructured":"Bhargava, P. et al. Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition. Brain 144, 1396\u20131408 (2021).","journal-title":"Brain"},{"key":"2359_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40478-023-01614-w","volume":"11","author":"KS Evonuk","year":"2023","unstructured":"Evonuk, K. S. et al. Bruton\u2019s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination. Acta Neuropathol. Commun. 11, 115 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"2359_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","volume":"19","author":"J Kramer","year":"2023","unstructured":"Kramer, J., Bar-Or, A., Turner, T. J. & Wiendl, H. Bruton tyrosine kinase inhibitors for multiple sclerosis. Nat. Rev. Neurol. 19, 289\u2013304 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2359_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin, V. et al. In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424\u2013436 (2010).","journal-title":"Immunity"},{"key":"2359_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233\u2013240 (2005).","journal-title":"J. Exp. Med."},{"key":"2359_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi0295","volume":"16","author":"AA Wang","year":"2024","unstructured":"Wang, A. A. et al. B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans. Sci. Transl. Med. 16, eadi0295 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2359_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","volume":"33","author":"M Absinta","year":"2020","unstructured":"Absinta, M., Lassmann, H. & Trapp, B. D. Mechanisms underlying progression in multiple sclerosis. Curr. Opin. Neurol. 33, 277\u2013285 (2020).","journal-title":"Curr. Opin. Neurol."},{"key":"2359_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.23882","volume":"74","author":"M Calabrese","year":"2013","unstructured":"Calabrese, M. et al. The changing clinical course of multiple sclerosis: a matter of gray matter. Ann. Neurol. 74, 76\u201383 (2013).","journal-title":"Ann. Neurol."},{"key":"2359_CR30","doi-asserted-by":"crossref","unstructured":"Florescu, A. et al. Dynamic alterations of dural and bone marrow B cells in an animal model of progressive multiple sclerosis. J. Exp. Med. 222 (2025).","DOI":"10.1084\/jem.20241255"},{"key":"2359_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nri1151","volume":"3","author":"JL Gommerman","year":"2003","unstructured":"Gommerman, J. L. & Browning, J. L. Lymphotoxin\/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3, 642\u2013655 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"2359_CR32","first-page":"1721","volume":"100","author":"DV Kuprash","year":"2002","unstructured":"Kuprash, D. V. et al. Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells. Blood 100, 1721\u20131727 (2002).","journal-title":"Blood"},{"key":"2359_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(00)80589-0","volume":"9","author":"PD Rennert","year":"1998","unstructured":"Rennert, P. D., James, D., Mackay, F., Browning, J. L. & Hochman, P. S. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9, 71\u201379 (1998).","journal-title":"Immunity"},{"key":"2359_CR34","doi-asserted-by":"crossref","unstructured":"Ahmed, S. M. et al. Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis. JCI Insight 7 (2022).","DOI":"10.1172\/jci.insight.151683"},{"key":"2359_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert, P. et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 21, 246\u2013257 (2022).","journal-title":"Lancet Neurol."},{"key":"2359_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43990-1","volume":"9","author":"A Abdelhak","year":"2019","unstructured":"Abdelhak, A., Huss, A., Kassubek, J., Tumani, H. & Otto, M. Author correction: serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci. Rep. 9, 8433 (2019).","journal-title":"Sci. Rep."},{"key":"2359_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta, M. et al. A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597, 709\u2013714 (2021).","journal-title":"Nature"},{"key":"2359_CR38","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/ana.25877","volume":"88","author":"P Maggi","year":"2020","unstructured":"Maggi, P. et al. Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study. Ann. Neurol. 88, 1034\u20131042 (2020).","journal-title":"Ann. Neurol."},{"key":"2359_CR39","doi-asserted-by":"crossref","unstructured":"Motamedgorji, N. et al. Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis. Neuroradiology (2025).","DOI":"10.1007\/s00234-025-03663-5"},{"key":"2359_CR40","doi-asserted-by":"publisher","first-page":"175628642413066","DOI":"10.1177\/17562864241306684","volume":"17","author":"A Dal-Bianco","year":"2024","unstructured":"Dal-Bianco, A., Oh, J., Sati, P. & Absinta, M. Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Ther. Adv. Neurol. Disord. 17, 17562864241306684 (2024).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"2359_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20021761","volume":"197","author":"DL Drayton","year":"2003","unstructured":"Drayton, D. L., Ying, X., Lee, J., Lesslauer, W. & Ruddle, N. H. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197, 1153\u20131163 (2003).","journal-title":"J. Exp. Med."},{"key":"2359_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fimmu.2014.00047","volume":"5","author":"TT Lu","year":"2014","unstructured":"Lu, T. T. & Browning, J. L. Role of the lymphotoxin\/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues. Front. Immunol. 5, 47 (2014).","journal-title":"Front. Immunol."},{"key":"2359_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.smim.2003.08.002","volume":"15","author":"T Cupedo","year":"2003","unstructured":"Cupedo, T. & Mebius, R. E. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin. Immunol. 15, 243\u2013248 (2003).","journal-title":"Semin. Immunol."},{"key":"2359_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.25197","volume":"83","author":"R Magliozzi","year":"2018","unstructured":"Magliozzi, R. et al. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann. Neurol. 83, 739\u2013755 (2018).","journal-title":"Ann. Neurol."},{"key":"2359_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309\u2013314 (2000).","journal-title":"Nature"},{"key":"2359_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1474-4422(14)70028-6","volume":"13","author":"L Kappos","year":"2014","unstructured":"Kappos, L. et al. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol. 13, 353\u2013363 (2014).","journal-title":"Lancet Neurol."},{"key":"2359_CR47","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.4049\/jimmunol.1800583","volume":"202","author":"P Haselmayer","year":"2019","unstructured":"Haselmayer, P. et al. Efficacy and pharmacodynamic modeling of the BTK inhibitor evobrutinib in autoimmune disease models. J. Immunol. 202, 2888\u20132906 (2019).","journal-title":"J. Immunol."},{"key":"2359_CR48","doi-asserted-by":"publisher","first-page":"e0143393","DOI":"10.1371\/journal.pone.0143393","volume":"10","author":"K Kannel","year":"2015","unstructured":"Kannel, K. et al. Changes in blood B cell-activating factor (BAFF) levels in multiple sclerosis: a sign of treatment outcome. PLoS ONE 10, e0143393 (2015).","journal-title":"PLoS ONE"},{"key":"2359_CR49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","volume":"176","author":"OL Rojas","year":"2019","unstructured":"Rojas, O. L. et al. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell 176, 610\u2013624 e618 (2019).","journal-title":"Cell"},{"key":"2359_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jon.12444","volume":"27","author":"DM Harrison","year":"2017","unstructured":"Harrison, D. M. et al. Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J. Neuroimaging 27, 461\u2013468 (2017).","journal-title":"J. Neuroimaging"},{"key":"2359_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1352458519885106","volume":"26","author":"J Zurawski","year":"2020","unstructured":"Zurawski, J. et al. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult. Scler. 26, 177\u2013187 (2020).","journal-title":"Mult. Scler."},{"key":"2359_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4049\/jimmunol.2000833","volume":"206","author":"V Ramaglia","year":"2021","unstructured":"Ramaglia, V., Florescu, A., Zuo, M., Sheikh-Mohamed, S. & Gommerman, J. L. Stromal cell-mediated coordination of immune cell recruitment, retention, and function in brain-adjacent regions. J. Immunol. 206, 282\u2013291 (2021).","journal-title":"J. Immunol."},{"key":"2359_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-immunol-093019-124155","volume":"39","author":"V Ramaglia","year":"2021","unstructured":"Ramaglia, V., Rojas, O., Naouar, I. & Gommerman, J. L. The ins and outs of central nervous system inflammation-lessons learned from multiple sclerosis. Annu Rev. Immunol. 39, 199\u2013226 (2021).","journal-title":"Annu Rev. Immunol."},{"key":"2359_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1352458519876037","volume":"26","author":"M Ighani","year":"2020","unstructured":"Ighani, M. et al. No association between cortical lesions and leptomeningeal enhancement on 7-tesla MRI in multiple sclerosis. Mult. Scler. 26, 165\u2013176 (2020).","journal-title":"Mult. Scler."},{"key":"2359_CR55","doi-asserted-by":"publisher","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","volume":"6","author":"JN Stern","year":"2014","unstructured":"Stern, J. N. et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci. Transl. Med. 6, 248ra107 (2014).","journal-title":"Sci. Transl. Med."},{"key":"2359_CR56","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/1352458511404916","volume":"17","author":"SD Roosendaal","year":"2011","unstructured":"Roosendaal, S. D. et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult. Scler. 17, 1098\u20131106 (2011).","journal-title":"Mult. Scler."},{"key":"2359_CR57","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/1352458509103176","volume":"15","author":"J Furby","year":"2009","unstructured":"Furby, J. et al. Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis. Mult. Scler. 15, 687\u2013694 (2009).","journal-title":"Mult. Scler."},{"key":"2359_CR58","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.neuroimage.2005.03.008","volume":"26","author":"MP Sanfilipo","year":"2005","unstructured":"Sanfilipo, M. P., Benedict, R. H., Sharma, J., Weinstock-Guttman, B. & Bakshi, R. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. NeuroImage 26, 1068\u20131077 (2005).","journal-title":"NeuroImage"},{"key":"2359_CR59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/01.WNL.0000055926.69643.03","volume":"60","author":"N De Stefano","year":"2003","unstructured":"De Stefano, N. et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60, 1157\u20131162 (2003).","journal-title":"Neurology"},{"key":"2359_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54430-8","volume":"15","author":"RC Gruber","year":"2024","unstructured":"Gruber, R. C. et al. BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis. Nat. Commun. 15, 10116 (2024).","journal-title":"Nat. Commun."},{"key":"2359_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03267-5","volume":"21","author":"J Langlois","year":"2024","unstructured":"Langlois, J. et al. Fenebrutinib, a Bruton\u2019s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. J. Neuroinflammation 21, 276 (2024).","journal-title":"J. Neuroinflammation"},{"key":"2359_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115609","volume":"44","author":"JS Kim","year":"2025","unstructured":"Kim, J. S. et al. Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice. Cell Rep. 44, 115609 (2025).","journal-title":"Cell Rep."},{"key":"2359_CR63","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.4049\/jimmunol.180.4.2284","volume":"180","author":"F Vu","year":"2008","unstructured":"Vu, F., Dianzani, U., Ware, C. F., Mak, T. & Gommerman, J. L. ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction. J. Immunol. 180, 2284\u20132293 (2008).","journal-title":"J. Immunol."},{"key":"2359_CR64","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","volume":"119","author":"LP Kil","year":"2012","unstructured":"Kil, L. P. et al. Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood 119, 3744\u20133756 (2012).","journal-title":"Blood"},{"key":"2359_CR65","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1078\/0171-2985-00192","volume":"206","author":"C Brunner","year":"2002","unstructured":"Brunner, C., Avots, A., Kreth, H. W., Serfling, E. & Schuster, V. Bruton\u2019s tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes. Immunobiology 206, 432\u2013440 (2002).","journal-title":"Immunobiology"},{"key":"2359_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti, S. et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol. 135, 511\u2013528 (2018).","journal-title":"Acta Neuropathol."},{"key":"2359_CR67","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer, J. M. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132, 1175\u20131189 (2009).","journal-title":"Brain"},{"key":"2359_CR68","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ana.24398","volume":"77","author":"I Michailidou","year":"2015","unstructured":"Michailidou, I. et al. Complement C1q\u2013C3-associated synaptic changes in multiple sclerosis hippocampus. Ann. Neurol. 77, 1007\u20131026 (2015).","journal-title":"Ann. Neurol."},{"key":"2359_CR69","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/brain\/awae013","volume":"147","author":"F Bagnato","year":"2024","unstructured":"Bagnato, F. et al. Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain 147, 2913\u20132933 (2024).","journal-title":"Brain"},{"key":"2359_CR70","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/acn3.51355","volume":"8","author":"A Gauthier","year":"2021","unstructured":"Gauthier, A. et al. Comparison of Simoa and Ella to assess serum neurofilament-light chain in multiple sclerosis. Ann. Clin. Transl. Neurol. 8, 1141\u20131150 (2021).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2359_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneuroim.2005.04.020","volume":"165","author":"F Giuliani","year":"2005","unstructured":"Giuliani, F., Fu, S. A., Metz, L. M. & Yong, V. W. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis. J. Neuroimmunol. 165, 83\u201391 (2005).","journal-title":"J. Neuroimmunol."},{"key":"2359_CR72","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.4049\/jimmunol.1700729","volume":"201","author":"G Galicia","year":"2018","unstructured":"Galicia, G. et al. Isotype-switched autoantibodies are necessary to facilitate central nervous system autoimmune disease in Aicda\u2212\/\u2212 and Ung\u2212\/\u2212 mice. J. Immunol. 201, 1119\u20131130 (2018).","journal-title":"J. Immunol."},{"key":"2359_CR73","doi-asserted-by":"publisher","first-page":"119008","DOI":"10.1016\/j.neuroimage.2022.119008","volume":"252","author":"A Arbabi","year":"2022","unstructured":"Arbabi, A. et al. Multiple-mouse magnetic resonance imaging with cryogenic radiofrequency probes for evaluation of brain development. NeuroImage 252, 119008 (2022).","journal-title":"NeuroImage"},{"key":"2359_CR74","doi-asserted-by":"publisher","unstructured":"Spencer Noakes, T. L., Henkelman, R. M. & Nieman, B. J. Partitioning k-space for cylindrical three-dimensional rapid acquisition with relaxation enhancement imaging in the mouse brain. NMR Biomed. https:\/\/doi.org\/10.1002\/nbm.3802 (2017).","DOI":"10.1002\/nbm.3802"},{"key":"2359_CR75","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","volume":"18","author":"DL Collins","year":"1994","unstructured":"Collins, D. L., Neelin, P., Peters, T. M. & Evans, A. C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192\u2013205 (1994).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"2359_CR76","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","volume":"54","author":"BB Avants","year":"2011","unstructured":"Avants, B. B. et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage 54, 2033\u20132044 (2011).","journal-title":"NeuroImage"},{"key":"2359_CR77","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/hbm.22092","volume":"34","author":"MM Chakravarty","year":"2013","unstructured":"Chakravarty, M. M. et al. Performing label-fusion-based segmentation using multiple automatically generated templates. Hum. Brain Mapp. 34, 2635\u20132654 (2013).","journal-title":"Hum. Brain Mapp."}],"updated-by":[{"DOI":"10.1038\/s41590-026-02442-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02359-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:03:12Z","timestamp":1769846592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02359-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02359-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5118485\/v1","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-026-02442-5","URL":"https:\/\/doi.org\/10.1038\/s41590-026-02442-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.G. has a shared patent on \u2018Methods of treating an autoimmune disease\u2019: WO2020102895A1, US20210401939A1, EP3883593A4 and CA3120454A1. The patent provides methods of treating an autoimmune disease (for example, multiple sclerosis) or reducing inflammation by administering at least a B cell activating Factor (BAFF) polypeptide to a subject in need thereof. The effect of BAFF on plasmablast\/plasma cells and their role in autoimmune diseases is also disclosed. D.S.R. has received research funding from Abata and Sanofi, related to but separate from his contribution to the current work. The other authors declare no competing interests. B.C. and B.N.-H. are employees of Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}